An Examination of Predictors of Indicators of Response to Celecoxib in Women Who Have a Diagnosis of Early Breast Cancer
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
To assess the quantitative real time PCR results results of oligonucleotide probes for a
number of gene transcription products that may be useful as predictors of indicators of
response to celecoxib.